rs6432893

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001365536.1(SCN9A):​c.2105-14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.49 in 1,494,214 control chromosomes in the GnomAD database, including 182,629 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 24870 hom., cov: 33)
Exomes 𝑓: 0.48 ( 157759 hom. )

Consequence

SCN9A
NM_001365536.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -0.857

Publications

11 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 2-166280609-G-A is Benign according to our data. Variant chr2-166280609-G-A is described in ClinVar as Benign. ClinVar VariationId is 167659.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.747 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.2105-14C>T intron_variant Intron 13 of 26 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.2105-14C>T intron_variant Intron 13 of 26 NM_001365536.1 ENSP00000495601.1 Q15858-1
SCN9AENST00000303354.11 linkc.2105-14C>T intron_variant Intron 13 of 26 5 ENSP00000304748.7 Q15858-1
SCN9AENST00000409672.5 linkc.2072-14C>T intron_variant Intron 13 of 26 5 ENSP00000386306.1 Q15858-3
SCN9AENST00000645907.1 linkc.2072-14C>T intron_variant Intron 13 of 26 ENSP00000495983.1 Q15858-4
SCN9AENST00000454569.6 linkc.2072-14C>T intron_variant Intron 13 of 14 1 ENSP00000413212.2 A0A0C4DG82

Frequencies

GnomAD3 genomes
AF:
0.557
AC:
84640
AN:
151914
Hom.:
24832
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.754
Gnomad AMI
AF:
0.316
Gnomad AMR
AF:
0.526
Gnomad ASJ
AF:
0.500
Gnomad EAS
AF:
0.377
Gnomad SAS
AF:
0.435
Gnomad FIN
AF:
0.486
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.485
Gnomad OTH
AF:
0.548
GnomAD2 exomes
AF:
0.493
AC:
79755
AN:
161820
AF XY:
0.484
show subpopulations
Gnomad AFR exome
AF:
0.761
Gnomad AMR exome
AF:
0.532
Gnomad ASJ exome
AF:
0.506
Gnomad EAS exome
AF:
0.376
Gnomad FIN exome
AF:
0.489
Gnomad NFE exome
AF:
0.478
Gnomad OTH exome
AF:
0.485
GnomAD4 exome
AF:
0.482
AC:
646768
AN:
1342182
Hom.:
157759
Cov.:
21
AF XY:
0.480
AC XY:
319087
AN XY:
665116
show subpopulations
African (AFR)
AF:
0.767
AC:
23397
AN:
30506
American (AMR)
AF:
0.526
AC:
18618
AN:
35402
Ashkenazi Jewish (ASJ)
AF:
0.506
AC:
12348
AN:
24412
East Asian (EAS)
AF:
0.383
AC:
13997
AN:
36580
South Asian (SAS)
AF:
0.442
AC:
34174
AN:
77370
European-Finnish (FIN)
AF:
0.482
AC:
23793
AN:
49332
Middle Eastern (MID)
AF:
0.458
AC:
2539
AN:
5546
European-Non Finnish (NFE)
AF:
0.477
AC:
490303
AN:
1027006
Other (OTH)
AF:
0.493
AC:
27599
AN:
56028
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
16458
32916
49373
65831
82289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14598
29196
43794
58392
72990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.557
AC:
84741
AN:
152032
Hom.:
24870
Cov.:
33
AF XY:
0.552
AC XY:
41049
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.754
AC:
31281
AN:
41502
American (AMR)
AF:
0.525
AC:
8013
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1734
AN:
3470
East Asian (EAS)
AF:
0.378
AC:
1945
AN:
5146
South Asian (SAS)
AF:
0.436
AC:
2106
AN:
4828
European-Finnish (FIN)
AF:
0.486
AC:
5130
AN:
10548
Middle Eastern (MID)
AF:
0.462
AC:
135
AN:
292
European-Non Finnish (NFE)
AF:
0.485
AC:
32956
AN:
67958
Other (OTH)
AF:
0.545
AC:
1153
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1811
3623
5434
7246
9057
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
710
1420
2130
2840
3550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.449
Hom.:
2281
Bravo
AF:
0.566
Asia WGS
AF:
0.444
AC:
1551
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 24, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 67% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 62. Only high quality variants are reported. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Primary erythromelalgia Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Channelopathy-associated congenital insensitivity to pain, autosomal recessive Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Paroxysmal extreme pain disorder Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Inherited Erythromelalgia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.13
DANN
Benign
0.53
PhyloP100
-0.86
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6432893; hg19: chr2-167137119; COSMIC: COSV57600629; COSMIC: COSV57600629; API